Cargando…
Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis
BACKGROUND: : Recombinant tissue plasminogen activator (rt-PA) is one of the most effective therapies for patients with acute ischemic stroke. However, wake-up stroke (WUS) is typically excluded from intravenous thrombolytic therapy because of the unclear time of symptom onset. Therefore, we aimed t...
Autores principales: | Liu, Hongfa, Hu, Weihua, Zhang, Fang, Gu, Wei, Hong, Jiankun, Chen, Jianping, Huang, Ying, Pan, Huoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282081/ https://www.ncbi.nlm.nih.gov/pubmed/35363213 http://dx.doi.org/10.1097/MD.0000000000028914 |
Ejemplares similares
-
Intravenous thrombolysis is more safe and effective for posterior circulation stroke: Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)
por: Tong, Xu, et al.
Publicado: (2016) -
Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit
por: Chtaou, Naima, et al.
Publicado: (2016) -
Utilization rates of intravenous thrombolysis for acute ischemic stroke in Asian countries:: A systematic review and meta-analysis
por: Gajurel, Bikram Prasad, et al.
Publicado: (2023) -
Is intravenous thrombolysis safe for acute ischemic stroke patients taking warfarin with INR 1.9?: A case report
por: Li, Zhaokun, et al.
Publicado: (2020) -
Risk factors of haemorrhagic transformation for acute ischaemic stroke in Chinese patients receiving intravenous thrombolysis: A meta-analysis
por: Wen, Lihong, et al.
Publicado: (2020)